u/Davidovv · 307d agono track record yet
$SLS on the verge of a massive break out
SLS has a phase 3 immunotherapy vaccine (GPS) for AML with positive interim data showing 13.5-month median survival, pending results this month that could unlock $4-6 billion in value for a current $300 million market cap. Strong institutional ownership and insider buying support upside if phase 3 results are positive.
At post $2.11Now $10.72+408.1% since postedas of Oct 19, 11:31 AM ET
1d+10.9%
3d+11.8%
1w+34.6%
1m+88.6%
3m+138.9%
6m+266.4%
1y—